Unlocking the health benefits of cannabinoids.

We are a team of medical experts.

Medical Advisory Board

Our Medical Advisory Board is made up of renowned Healthcare Professionals whose unique perspectives and expertise inform the strategic direction and success of the company.

Political Advisory Board

Our Political Advisory Board comprises renowned political experts and healthcare professionals who provide strategic guidance and advice to support Sanity Group to meet its mission and objectives.

Latest News

Vayamed Cannakits®: Innovative cannabis formulation kits enable new forms of application for an expanded therapy spectrum – experienced therapists sought for clinical support survey

Berlin-based medical cannabis specialist Vayamed is launching a formulation innovation designed to open up new possibilities in cannabis therapy: The Vayamed Cannakits® are special formulation kits based on an innovative two-syringe technology and contain all ingredients for the standardized production of cannabinoid-based new dosage forms in pharmacies. The first version of the Vayamed Cannakits®, which is available at pharmacies now, is especially designed for doctors with cannabis therapy experience who would like to use the product for selected patients in individual therapeutic trials within their own therapeutic jurisdiction.

Read more

Sanity Group at the hemp fair Mary Jane and ICBC Berlin 2022

On July 15-17, 2022, Germany’s largest hemp fair “Mary Jane” will take place in Berlin. A few days later, on July 19 and 20, 2022, the International Cannabis Business Conference (ICBC) will also take place in Germany’s capital. The Sanity Group, one of Germany’s leading cannabis companies, will be represented at both events with booths, and is also a sponsor of the ICBC.

Read more

Vayamed and telemedicine pioneer Telaleaf launch exclusive partnership

German medical cannabis specialist Vayamed and the telemedicine platform Telaleaf agreed on an exclusive partnership to strengthen telemedicine in cannabis therapy in Germany. The focus will be on therapy quality, patient centered pricing, individual therapy plans, and equitable therapy access. Telaleaf is a pioneer in cannabis-based telemedicine from Canada established in 2020 and will now launch its services in the German healthcare system.

Read more